Published in Gene Therapy Weekly, December 26th, 2002
Researchers have used hepatocyte growth factor gene therapy to improve cardiac function in a rapid pacing-induced heart failure canine model. They contend the novel gene therapy demonstrates potential for treating human heart failure.
According to Ismayil Ahmet and coauthors, Osaka University Medical School, Osaka, Japan, hepatocyte growth factor is known to increase angiogenesis and staunch apoptosis and fibrosis. The gene therapy, containing a hemagglutinating virus of Japan (Sendai virus)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.